Cuproptosis-Related LncRNA Signature for Predicting Prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cuproptosis-Related LncRNA Signature for Predicting Prognosis of Hepatocellular Carcinoma: A Comprehensive Analysis
Authors
Keywords
-
Journal
DISEASE MARKERS
Volume 2022, Issue -, Pages 1-16
Publisher
Hindawi Limited
Online
2022-11-22
DOI
10.1155/2022/3265212
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis
- (2022) Yadong Liu et al. Bioengineered
- Tumor mutation burden for predicting immune checkpoint blockade response: the more, the better
- (2022) Ming Zheng Journal for ImmunoTherapy of Cancer
- Copper induces cell death by targeting lipoylated TCA cycle proteins
- (2022) Peter Tsvetkov et al. SCIENCE
- Construction of a ceRNA Network and Comprehensive Analysis of lncRNA in Hepatocellular Carcinoma
- (2022) Lin Wang et al. Genes
- Selective Targeting of Cancer Cells by Copper Ionophores: An Overview
- (2022) Valentina Oliveri Frontiers in Molecular Biosciences
- BERT-Promoter: An improved sequence-based predictor of DNA promoter using BERT pre-trained model and SHAP feature selection
- (2022) Nguyen Quoc Khanh Le et al. COMPUTATIONAL BIOLOGY AND CHEMISTRY
- lncRNA PCAT6 facilitates cell proliferation and invasion via regulating the miR‑326/hnRNPA2B1 axis in liver cancer
- (2021) Jun Luo et al. Oncology Letters
- Long noncoding RNA CYTOR triggers gastric cancer progression by targeting miR-103/RAB10
- (2021) Fang Wei et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- lncRNA CYTOR promotes cell proliferation and tumor growth via miR‑125b/SEMA4C axis in hepatocellular carcinoma
- (2021) Qing Tian et al. Oncology Letters
- lncRNA LOXL1‑AS1 promotes liver cancer cell proliferation and migration by regulating the miR‑377‑3p/NFIB axis
- (2021) Wei Yu et al. Oncology Letters
- LncRNA NKILA Promotes Epithelial-Mesenchymal Transition of Liver Cancer Cells by Targeting miR-485-5p
- (2021) Yuxu Wang et al. Journal of Oncology
- Role of Copper on Mitochondrial Function and Metabolism
- (2021) Lina M. Ruiz et al. Frontiers in Molecular Biosciences
- Improved Prediction Model of Protein Lysine Crotonylation Sites Using Bidirectional Recurrent Neural Networks
- (2021) Sian Soo Tng et al. JOURNAL OF PROTEOME RESEARCH
- Deep transformers and convolutional neural network in identifying DNA N6-methyladenine sites in cross-species genomes
- (2021) Nguyen Quoc Khanh Le et al. METHODS
- Treg-Cell-Derived IL-35-Coated Extracellular Vesicles Promote Infectious Tolerance
- (2020) Jeremy A. Sullivan et al. Cell Reports
- lncRNA HAND2-AS1 Inhibits Liver Cancer Cell Proliferation and Migration by Upregulating SOCS5 to Inactivate the JAK-STAT Pathway
- (2020) Daojie Yan et al. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
- Colorectal cancer and trace elements alteration
- (2020) Jovan T. Juloski et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
- (2020) Wang Li et al. Frontiers in Oncology
- Copper metabolism as a unique vulnerability in cancer
- (2020) Vinit C. Shanbhag et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Serum copper, zinc and metallothionein serve as potential biomarkers for hepatocellular carcinoma
- (2020) Yasuyuki Tamai et al. PLoS One
- LncRNA ZEB1‑AS1 reduces liver cancer cell proliferation by targeting miR‑365a‑3p
- (2019) Mingfei Li et al. Experimental and Therapeutic Medicine
- LINC00205 promotes proliferation, migration and invasion of HCC cells by targeting miR-122-5p
- (2019) Lei Zhang et al. PATHOLOGY RESEARCH AND PRACTICE
- Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence
- (2019) Samuel J. Klempner et al. ONCOLOGIST
- Challenges in liver cancer and possible treatment approaches
- (2019) David Anwanwan et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Long noncoding RNA cytoskeleton regulator RNA promotes cell invasion and metastasis by titrating miR‐613 to regulate ANXA2 in nasopharyngeal carcinoma
- (2019) Wei Chen et al. Cancer Medicine
- Hepatocellular carcinoma in the era of immunotherapy
- (2018) Hao-Wen Sim et al. CURRENT PROBLEMS IN CANCER
- Long noncoding RNA CYTOR sponges miR-195 to modulate proliferation, migration, invasion and radiosensitivity in nonsmall cell lung cancer cells
- (2018) Jun Zhang et al. BIOSCIENCE REPORTS
- TP53 mutations as potential prognostic markers for specific cancers: analysis of data from The Cancer Genome Atlas and the International Agency for Research on Cancer TP53 Database
- (2018) Victor D. Li et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Long Noncoding RNAs in Cancer Pathways
- (2016) Adam M. Schmitt et al. CANCER CELL
- Portraying breast cancers with long noncoding RNAs
- (2016) O. Van Grembergen et al. Science Advances
- The landscape of long noncoding RNAs in the human transcriptome
- (2015) Matthew K Iyer et al. NATURE GENETICS
- Copper: toxicological relevance and mechanisms
- (2014) Lisa M. Gaetke et al. ARCHIVES OF TOXICOLOGY
- Long Noncoding RNA GAPLINC Regulates CD44-Dependent Cell Invasiveness and Associates with Poor Prognosis of Gastric Cancer
- (2014) Y. Hu et al. CANCER RESEARCH
- Copper as a key regulator of cell signalling pathways
- (2014) Alexandra Grubman et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- BRAFV600Eremodels the melanocyte transcriptome and inducesBANCRto regulate melanoma cell migration
- (2012) Ross J. Flockhart et al. GENOME RESEARCH
- International Trends in Liver Cancer Incidence Rates
- (2011) M. M. Center et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started